CD44 and non-small cell lung carcinoma: Our analysis of collected lung cancer specimens revealed elevated expression levels of DNMT1, CD44, and SOS1 in certain NSCLC tissues, establishing a positive correlation between DNMT1 and SOS1 in the progression of NSCLC.